Physician profile
Joseph B Bernstein
NPI 1013954163
$3,062.44
in general payments reported to CMS, 2019-2025
20 companies · $24.65 in 2025
The $24.65 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $984 · 2020: $554 · 2021: $713 · 2022: $542 · 2024: $246 · 2025: $24.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $510.52 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $352.12 | 2020-2022 | |
| Abbvie INC. | $339.11 | 2019-2021 | |
| Amgen INC. | $269.40 | 2019 | |
| Amarin Pharma, INC. | $256.67 | 2019-2021 | |
| Lilly USA, LLC | $218.82 | 2020-2024 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2021 | |
| Glaxosmithkline, LLC. | $122.19 | 2019 | |
| Phathom Pharmaceuticals, INC. | $120.53 | 2024 | Voquezna |
| Boston Scientific Corporation | $115.61 | 2019 | |
| Merck Sharp & Dohme LLC | $106.28 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $101.69 | 2019 | |
| Horizon Therapeutics Plc | $95.24 | 2019-2022 | |
| Allergan, INC. | $71.83 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $51.21 | 2020-2021 | |
| Axsome Therapeutics, INC. | $24.65 | 2025 | Symbravo |
| Bausch Health US, LLC | $23.16 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.37 | 2019 | |
| Althera Pharmaceuticals LLC | $15.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.